Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Empower International Growth Inv MXIGX
- NAV / 1-Day Return 13.55 / +0.59 %
- Total Assets 510.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.200%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 63%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 12:24 AM GMT+0
Morningstar’s Analysis MXIGX
Will MXIGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
ASML Holding NV | 4.46 | 21.2 Mil | Technology |
Nestle SA | 2.96 | 14.1 Mil | Consumer Defensive |
Novo Nordisk A/S Class B | 2.73 | 13.0 Mil | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 1.95 | 9.3 Mil | Consumer Cyclical |
Genmab A/S | 1.89 | 9.0 Mil | Healthcare |
Dsv A/S | 1.85 | 8.8 Mil | — |
Kinaxis Inc | 1.77 | 8.4 Mil | Technology |
MTU Aero Engines AG | 1.76 | 8.4 Mil | Industrials |
Air Liquide SA | 1.76 | 8.4 Mil | Basic Materials |
AstraZeneca PLC | 1.76 | 8.4 Mil | Healthcare |